Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Each year, the global oncology community flocks to Chicago to convene at the American Society of Clinical Oncology’s ann | Each year, the global oncology community descends on Chicago for ASCO, where buzzy data drops, practice-changing posters and packed sessions offer a look at where cancer care is headed next. In this week’s episode of “The Top Line,” Fierce Biotech’s Darren Incorvaia and Fierce Pharma’s Zoey Becker and Angus Liu break down the biggest takeaways from their weekend reporting live from the Windy City, from “nutty” in vivo CAR-T data to a historic first for a Chinese biotech asset.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

There were 487 exhibitor booths at the American Society of Clinical Oncology (ASCO)’s 2026 annual meeting, held in Chicago’s…

A recurring theme at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting wasn’t a single dataset, biomarker, or…

In 2017, a little-known company called Nanjing Legend Biotech walked into the ASCO annual meeting at the 11th hour, dropped a…

This week on "The Top Line," we’re covering some of the biggest stories across biopharma before turning to one of the industry’s…

This week on “The Top Line,” Fierce Healthcare and Life Sciences’ editor-in-chief steps behind the microphone for a solo episode…

Here is some of what you may have missed from the world's largest cancer research meeting.